The three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct.
about
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylationGlycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response elementcAMP response element binding protein (CREB) activates transcription via two distinct genetic elements of the human glucose-6-phosphatase geneNegative regulators of insulin signaling revealed in a genome-wide functional screenTranscriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalphaAcute exercise modulates the Foxo1/PGC-1alpha pathway in the liver of diet-induced obesity ratsThe synergistic effect of dexamethasone and all-trans-retinoic acid on hepatic phosphoenolpyruvate carboxykinase gene expression involves the coactivator p300Insulin and epidermal growth factor suppress basal glucose-6-phosphatase catalytic subunit gene transcription through overlapping but distinct mechanisms.FoxO1 mediates an autofeedback loop regulating SIRT1 expression.Insulin regulates retinol dehydrogenase expression and all-trans-retinoic acid biosynthesis through FoxO1.Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.Targeting glycogen synthase kinase-3 in insulin signalling.Transcriptional regulation by insulin: from the receptor to the gene.Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes.The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.Identification and characterization of a novel 5 bp deletion in a putative insulin response element in the lipoprotein lipase gene.Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction.Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymesRepression of glucocorticoid-stimulated angiopoietin-like 4 gene transcription by insulin.FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells.Zinc-dependent effects of small molecules on the insulin-sensitive transcription factor FOXO1a and gluconeogenic genes.COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression.Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase.rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study.Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1.Analysis of hepatic gene transcription in mice expressing insulin-insensitive GSK3.Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alphaSTAT3 targets the regulatory regions of gluconeogenic genes in vivoDeficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure.Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytesClass IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin.In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex.SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding.Crystal structures reveal a new and novel FoxO1 binding site within the human glucose-6-phosphatase catalytic subunit 1 gene promoter.The anti-neurodegenerative agent clioquinol regulates the transcription factor FOXO1a.
P2860
Q24534597-1617D165-127C-470C-988D-8820D4AE83F6Q24793511-0A1A1B6B-C2FF-46D0-AE9A-9814FEBC3DBBQ24800260-C019E813-E389-41F7-B993-420AB24E1143Q28476047-F5C0E743-FCC5-4E2B-87F5-EDD478285842Q28565514-7C6F42A6-BB86-48F8-ABCB-557175688E5EQ28572637-C944C839-B667-4DE1-A5B5-55AF3431096BQ28573652-9976E434-D7E5-42ED-9165-09012AF2A252Q34089344-672CDABD-0A6D-4F5C-94A2-4B3574470AD8Q34568424-F75691D5-9B56-4FB5-8B46-A32F9ED57803Q35172702-D654F6C3-20C0-447E-ABFF-DD5543492C29Q35568513-1923FAD2-5DDA-45B8-B8FA-FF177AC0247EQ35860656-784000FF-FBBD-48F1-8C8D-4F893B27B1C8Q36481069-9DBE5929-F0B1-4F42-B989-30EE3184B3A3Q36602626-5AA6B434-EDEA-462B-953E-A500067ABF2DQ36884737-6E2AD54A-C7EE-4838-B055-60B60F2834B4Q37120241-E9C40BB6-A70F-4EEC-ADFB-2C68A95D4334Q37366587-8DCEBFDB-40F8-4CB5-A55E-DD07A3244A24Q37389319-7024B6F4-DAB0-4BC5-8AEA-70BB0D03CFB4Q37493137-87DBFA71-15C3-4D83-8C9B-A559253AB9D4Q37716367-887C74E8-096E-46D0-BDAC-F72625B8E331Q38728466-5635F0CA-5C7F-4563-AA80-4ADFC65BBBBCQ39633310-0A470BDE-5E4C-4328-BAA7-DE32C5ADBC52Q39936163-E8317EF0-1C87-4596-9EF1-07B9CA7B0DEBQ40223088-C6066272-D2A4-400E-A9EC-3495D72E8764Q40261669-4EE09273-5417-4266-BF30-4A35D0C8131DQ40363311-1967A461-0173-422D-9EA5-F732A7787CF5Q40572878-FA649DC1-C5B9-42E4-ABCA-5AADD52A72D8Q40679129-1CEF7410-9807-4292-9CD3-1174FAF1D5AAQ41517260-D5A2AC5E-77A0-4A23-9F9D-5782BB932765Q41810904-ECE2760F-E9EE-4FFA-9E1B-D3FC28B9F75AQ41824865-39B3360B-BD4D-4972-A82A-206FF13F4CC5Q42156584-61B0E33E-66BE-4606-8D68-56ADB69D33FBQ42681991-8EA29564-2B95-4F6E-922C-6140FC841A02Q42924976-E3775666-8711-4840-97C3-0DCD155E0B87Q45876893-844ABB5D-EED5-4CE0-A02B-1891790C4DB2Q47637379-140AD81D-E7E6-4573-97FF-DB6067C2638BQ47887307-7DFEAC11-C21F-4E78-B2E9-9BDFE1FD493AQ48322350-142D21DC-EEB6-4F3F-AF30-1B9574898EECQ51128779-58CBD7D8-5FFD-4F31-9CF4-AE7DD03E3B81Q54536013-F31A3976-59E8-41EA-B2BC-021B5D99DD9A
P2860
The three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The three insulin response seq ...... ter are functionally distinct.
@en
The three insulin response seq ...... ter are functionally distinct.
@nl
type
label
The three insulin response seq ...... ter are functionally distinct.
@en
The three insulin response seq ...... ter are functionally distinct.
@nl
prefLabel
The three insulin response seq ...... ter are functionally distinct.
@en
The three insulin response seq ...... ter are functionally distinct.
@nl
P2093
P2860
P356
P1476
The three insulin response seq ...... ter are functionally distinct.
@en
P2093
Beth T Vander Kooi
Christina A Svitek
David R Powell
James K Oeser
Richard M O'Brien
Ryan S Streeper
P2860
P304
11782-11793
P356
10.1074/JBC.M212570200
P407
P577
2003-01-28T00:00:00Z